세계의 파라아미노페놀 시장 : 형태, 등급, 판매 채널, 용도, 지역별 분석(-2032년)

According to Stratistics MRC, the Global Para Aminophenol Market is accounted for $3.01 billion in 2025 and is expected to reach $4.63 billion by 2032 growing at a CAGR of 6.3% during the forecast period. Para-Aminophenol (PAP) is an organic compound with the chemical formula C6H7NO. It is a crystalline solid primarily used in the production of acetaminophen (paracetamol), a common analgesic and antipyretic. PAP is also employed in the manufacturing of dyes and pigments, especially in the textile industry, and in the production of certain chemicals used in photography and imaging. Its versatile applications in pharmaceuticals, chemicals, and cosmetics make it a critical raw material in various industries.

Market Dynamics:

Driver:

Growing demand for acetaminophen

Acetaminophen, also known as paracetamol, is widely used as an over-the-counter medication for pain relief and fever reduction. The need for acetaminophen is being driven by the rising incidence of chronic illnesses and pain-management-related ailments such arthritis and post-operative pain. Increased acetaminophen consumption is also a result of the aging population and growing understanding of pain management options. Since acetaminophen is made from roughly 80% of PAP produced worldwide, the market for acetaminophen has a direct impact on PAP demand.

Restraint:

Volatility in raw material prices

Volatility in raw material prices is a significant restraint for the Para-Aminophenol (PAP) market, as fluctuations in the cost of key inputs, such as aniline and other chemical precursors, directly affect production costs. Price instability can lead to uncertainty for manufacturers, impacting their ability to maintain consistent pricing strategies. This unpredictability may also force companies to adjust their profit margins, increase product prices, or delay production schedules. Additionally, reliance on suppliers from different regions, with varying economic conditions, further exacerbates the challenge, making it difficult for companies to plan and manage production costs effectively in the long term.

Opportunity:

Expansion of pharmaceutical industry

The increased demand for over-the-counter drugs like acetaminophen (paracetamol), which is produced from PAP, is a result of the growing healthcare demands worldwide, especially in emerging nations. The necessity for PAP in pharmaceutical manufacture is further increased by the rising popularity of fever-reducing and pain-management therapies. PAP use is also increased in developing nations due to the development of healthcare infrastructure and increased availability to pharmaceuticals. This expansion is expected to support continued growth in the pharmaceutical segment of the PAP market.

Threat:

Supply chain disruptions

The para-aminophenol (PAP) market is severely challenged by supply chain interruptions, which can impair raw material availability, postpone manufacturing plans, and have an impact on distribution networks. Transportation of essential chemical precursors and final goods may be delayed by occurrences such as the COVID-19 pandemic, natural disasters, or geopolitical tensions. Increased lead times, greater operating expenses and perhaps fewer products available on the market are the results of these disruptions. Additionally, manufacturers might have trouble finding reliable sources of raw materials at affordable costs, which could affect their capacity to satisfy demand and stay profitable.

Covid-19 Impact:

The COVID-19 pandemic disrupted the Para-Aminophenol (PAP) market by causing supply chain delays and temporary closures of manufacturing facilities, affecting production volumes. However, the demand for PAP in pharmaceutical applications, particularly for acetaminophen (paracetamol), surged as people sought over-the-counter medications for fever and pain relief. The pharmaceutical sector showed resilience, while the textile and dye industries faced slowdowns. Post-pandemic recovery is expected to drive steady growth in the PAP market.

The E-commerce segment is expected to be the largest during the forecast period

The E-commerce segment is expected to account for the largest market share during the forecast period driven by enabling easier access to raw materials for manufacturers and suppliers. Online platforms offer a convenient way for businesses to procure PAP for pharmaceutical, chemical, and cosmetic applications. E-commerce also facilitates direct transactions, reduces distribution costs, and widens the customer base, particularly for small and medium-sized enterprises, contributing to increased market accessibility and overall growth in the PAP industry.

The pharmaceuticals segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the pharmaceuticals segment is predicted to witness the highest growth rate due to the rising demand for acetaminophen (paracetamol), a widely used analgesic and antipyretic. As healthcare needs rise globally, especially in emerging markets, the demand for PAP to produce pain relief medications continues to increase. Additionally, advancements in healthcare infrastructure and expanding over-the-counter drug accessibility further boost the demand for PAP in the pharmaceutical industry.

Region with largest share:

During the forecast period, the Asia Pacific region is expected to hold the largest market share driven by rapid industrialization, growing pharmaceutical production, and expanding textile and cosmetic industries. The rising demand for acetaminophen in countries like China and India fuels the pharmaceutical sector, while the increasing use of PAP in dyes and pigments supports the textile and personal care industries. Moreover, cost-effective manufacturing and a large consumer base further contribute to the robust growth of the PAP market in this region.

Region with highest CAGR:

Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, due to the growing demand for pain relievers and fever-reducing medications boosts PAP consumption. Additionally, North America's well-established pharmaceutical sector fosters market expansion, while increasing demand for advanced dyes in textiles and cosmetics further drives growth. This trend strengthens the region's influence in the global PAP market.

Key players in the market

Some of the key players in Para Aminophenol Market include BASF SE, Lanxess AG, Merck Group, Eastman Chemical Company, Sumitomo Chemical Co., Ltd., Hunan Lerk Pharmaceutical Co., Ltd., Aarti Industries Ltd., Arkema Group, Daiichi Sankyo Co., Ltd., Chongqing Changfeng Chemical Co., Ltd., Anhui Bayi Chemical Industry Co., Ltd., Jiangsu Huanxin Pharmaceutical Co., Ltd., Shandong Xinhua Pharmaceutical Co., Ltd., Lianyungang Dongjin Chemical Co., Ltd., and Taizhou Zhongtai Chemical Co., Ltd.

Key Developments:

In January 2025, BASF's Personal Care business is launching a new ingredient, VitaGuard (R)A to capture the continuous market demand for retinol, while reinforcing its position as a Hero ingredient in cosmetics. This latest innovation is based on the encapsulation of free retinol. VitaGuard(R) A was developed using patented solid lipid particles, protecting retinol from degradation, limiting skin irritation and allowing better skin bioavailability for improved cosmetic efficacy.

In January 2025, Eastman introduced the latest innovation in its sustainable fiber portfolio today at Heimtextil trade fair in Frankfurt, Germany. Eastman Naia(TM) Renew cellulosic fiber for fill applications expands beyond the brand's success in bedding and towels. The fiber transforms comforters and quilts with breathable comfort, luxurious softness and unparalleled ease of care.

Forms Covered:

• Powder
• Crystals
• Liquids

Grades Covered:

• Pharmaceutical Grade
• Technical Grade

Sales Channels Covered:

• Distribution Channels
• Direct Sales
• E-commerce

Applications Covered:

• Hair Dye Intermediates
• Rubber Chemicals
• Pharmaceuticals
• Electronics
• Other Applications

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

• 2.1 Abstract
• 2.2 Stake Holders
• 2.3 Research Scope
• 2.4 Research Methodology
  • 2.4.1 Data Mining
  • 2.4.2 Data Analysis
  • 2.4.3 Data Validation
  • 2.4.4 Research Approach
• 2.5 Research Sources
  • 2.5.1 Primary Research Sources
  • 2.5.2 Secondary Research Sources
  • 2.5.3 Assumptions

3 Market Trend Analysis

• 3.1 Introduction
• 3.2 Drivers
• 3.3 Restraints
• 3.4 Opportunities
• 3.5 Threats
• 3.6 Application Analysis
• 3.7 Emerging Markets
• 3.8 Impact of Covid-19

4 Porters Five Force Analysis

• 4.1 Bargaining power of suppliers
• 4.2 Bargaining power of buyers
• 4.3 Threat of substitutes
• 4.4 Threat of new entrants
• 4.5 Competitive rivalry

5 Global Para Aminophenol Market, By Form

• 5.1 Introduction
• 5.2 Powder
• 5.3 Crystals
• 5.4 Liquids

6 Global Para Aminophenol Market, By Grade

• 6.1 Introduction
• 6.2 Pharmaceutical Grade
• 6.3 Technical Grade

7 Global Para Aminophenol Market, By Sales Channel

• 7.1 Introduction
• 7.2 Distribution Channels
• 7.3 Direct Sales
• 7.4 E-commerce

8 Global Para Aminophenol Market, By Application

• 8.1 Introduction
• 8.2 Hair Dye Intermediates
• 8.3 Rubber Chemicals
• 8.4 Pharmaceuticals
• 8.5 Electronics
• 8.6 Other Applications

9 Global Para Aminophenol Market, By Geography

• 9.1 Introduction
• 9.2 North America
  • 9.2.1 US
  • 9.2.2 Canada
  • 9.2.3 Mexico
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 Italy
  • 9.3.4 France
  • 9.3.5 Spain
  • 9.3.6 Rest of Europe
• 9.4 Asia Pacific
  • 9.4.1 Japan
  • 9.4.2 China
  • 9.4.3 India
  • 9.4.4 Australia
  • 9.4.5 New Zealand
  • 9.4.6 South Korea
  • 9.4.7 Rest of Asia Pacific
• 9.5 South America
  • 9.5.1 Argentina
  • 9.5.2 Brazil
  • 9.5.3 Chile
  • 9.5.4 Rest of South America
• 9.6 Middle East & Africa
  • 9.6.1 Saudi Arabia
  • 9.6.2 UAE
  • 9.6.3 Qatar
  • 9.6.4 South Africa
  • 9.6.5 Rest of Middle East & Africa

10 Key Developments

• 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
• 10.2 Acquisitions & Mergers
• 10.3 New Product Launch
• 10.4 Expansions
• 10.5 Other Key Strategies

11 Company Profiling

• 11.1 BASF SE
• 11.2 Lanxess AG
• 11.3 Merck Group
• 11.4 Eastman Chemical Company
• 11.5 Sumitomo Chemical Co., Ltd.
• 11.6 Hunan Lerk Pharmaceutical Co., Ltd.
• 11.7 Aarti Industries Ltd.
• 11.8 Arkema Group
• 11.9 Daiichi Sankyo Co., Ltd.
• 11.10 Chongqing Changfeng Chemical Co., Ltd.
• 11.11 Anhui Bayi Chemical Industry Co., Ltd.
• 11.12 Jiangsu Huanxin Pharmaceutical Co., Ltd.
• 11.13 Shandong Xinhua Pharmaceutical Co., Ltd.
• 11.14 Lianyungang Dongjin Chemical Co., Ltd.
• 11.15 Taizhou Zhongtai Chemical Co., Ltd.